Search Results

Treatment-experienced breast cancer: New pathways for improving survival.

• Authors : Michaud, Laura Boehnke¹

Subjects: *BREAST cancer; *CANCER treatment; *CANCER in women

• Source: American Journal of Health-System Pharmacy. 5/15/2008 Supplement, Vol. 65 Issue S3, pS23-S24. 2p.

Record details

Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer.

• Authors : McBride, Ali¹ ; Butler, Sara K.

Subjects: *ANTINEOPLASTIC agents; *BREAST tumors; *DRUG side effects

• Source: American Journal of Health-System Pharmacy. 5/1/2012, Vol. 69 Issue 9, p745-755. 11p. 1 Diagram, 3 Charts, 1 Graph.

Record details

FDA approves pertuzumab for breast cancer.

• Authors : Traynor, Kate

Subjects: *BREAST tumors; *COMBINATION drug therapy; *DRUG allergyUNITED States. Food & Drug Administration

• Source: American Journal of Health-System Pharmacy. 7/15/2012, Vol. 69 Issue 14, p1178-1178. 2/3p.

Record details

Specialty pharmacy services for patients receiving oral medications for solid tumors.

• Authors : Stein, Jill¹ ; Mann, Janelle^2,3

Subjects: *ACADEMIC medical centers; *BREAST tumors; *COMBINATION drug therapyIOWA; MISSOURI

• Source: American Journal of Health-System Pharmacy. 6/1/2016, Vol. 73 Issue 11, p775-796. 22p. 5 Charts.

Record details

Clinical and economic benefits of aromatase inhibitor therapy in early-stage breast cancer.

• Authors : Glück, Stefan¹ ; Gorouhi, Fariborz²

Subjects: *DRUG side effects; *BREAST tumors; *COST effectiveness

• Source: American Journal of Health-System Pharmacy. 9/15/2011, Vol. 68 Issue 18, p1699-1706. 8p. 1 Diagram, 3 Charts.

Record details

Trastuzumab and cardiotoxicity: Weighing the risks.

• Authors : Siu-Fun Wong¹

Subjects: *TRASTUZUMAB; *ANTINEOPLASTIC agents; *DRUG therapy

• Source: American Journal of Health-System Pharmacy. 3/15/2006, Vol. 63 Issue 6, p525. 1p.

Record details

Summaries of safety labeling changes approved by FDA—Boxed warnings highlights, April–June 2021.

Subjects: *PROGESTERONE; *ESTRADIOL; *MONOCLONAL antibodiesUNITED States. Food & Drug Administration

• Source: American Journal of Health-System Pharmacy. Oct2021, Vol. 78 Issue 19, pe9-e10. 2p.

Record details

DIR fees pose a 5-star problem for pharmacies.

• Authors : Traynor, Kate

Subjects: *CLINICAL medicine; *HOSPITAL pharmacies; *LABOR incentives

• Source: American Journal of Health-System Pharmacy. 4/15/2017, Vol. 74 Issue 8, p546-548. 3p. 1 Illustration.

Record details

Cancer-treatment-induced bone loss, part 1.

• Authors : Michaud, Laura Boehnke¹ ; Goodin, Susan^2,3

Subjects: *DRUG side effects; *BONE injuries; *BONE cancer

• Source: American Journal of Health-System Pharmacy. 3/1/2006, Vol. 63 Issue 5, p419-430. 12p. 1 Diagram.

Record details

Government uncovers obstacles to personalized health care.

• Authors : Thompson, Cheryl A.

Subjects: *MEDICAL care; *CLINICAL trials; *CLINICAL medicineUNITED States

• Source: American Journal of Health-System Pharmacy. 8/1/2008, Vol. 65 Issue 15, p1399-1400. 2p.

Record details